Frédèric Selle
Impact in
- Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research
- PARP inhibition in cancer therapy
Papers in
-
- Ovarian cancer diagnosis and treatment 75
- Oncology 58
- PARP inhibition in cancer therapy 24
- Cancer Treatment and Pharmacology 9
- Co-authors
- Thierry André (6 shared papers)Christophe Louvet (5 shared papers)Roman Rouzier (18 shared papers)Émile Daraï (14 shared papers)E. Chéreau (15 shared papers)Jean‐Pierre Lotz (20 shared papers)Pascal Hammel (3 shared papers)Philippe Ruszniewski (2 shared papers)
In The Last Decade
Frédèric Selle
123 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 75
- Reproductive Medicine 986
- Oncology 1.2k
- Obstetrics and Gynecology 306
- Surgery 637
- Cancer Research 172
Countries citing papers authored by Frédèric Selle
This map shows the geographic impact of Frédèric Selle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédèric Selle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédèric Selle more than expected).
Fields of papers citing papers by Frédèric Selle
This network shows the impact of papers produced by Frédèric Selle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédèric Selle. The network helps show where Frédèric Selle may publish in the future.
Co-authors
The 25 scholars most cited alongside Frédèric Selle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 132 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 398 | |
| 2 | 2004 | 317 | |
| 3 | 2017 | 116 | |
| 4 | 2020 | 95 | |
| 5 | 2021 | 84 | |
| 6 | 2010 | 80 | |
| 7 | 2016 | 78 | |
| 8 | 2010 | 73 | |
| 9 | 2017 | 57 | |
| 10 | 2016 | 55 | |
| 11 | 2017 | 54 | |
| 12 | 2016 | 53 | |
| 13 | 2018 | 52 | |
| 14 | 2010 | 46 | |
| 15 | 2006 | 44 | |
| 16 | 2021 | 43 | |
| 17 | 2014 | 38 | |
| 18 | 2001 | 35 | |
| 19 | 2020 | 33 | |
| 20 | 2012 | 31 |
About Frédèric Selle
Frédèric Selle is a scholar working on Reproductive Medicine, Oncology, Pulmonary and Respiratory Medicine, Surgery and Obstetrics and Gynecology, having authored 132 papers that have together received 2.6k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (75 papers), PARP inhibition in cancer therapy (24 papers), Renal cell carcinoma treatment (19 papers), Endometrial and Cervical Cancer Treatments (13 papers), Intraperitoneal and Appendiceal Malignancies (11 papers), Cancer Treatment and Pharmacology (9 papers), Testicular diseases and treatments (8 papers) and BRCA gene mutations in cancer (8 papers). The work is most often cited by research in Reproductive Medicine (986 citations), Oncology (1.2k citations), Obstetrics and Gynecology (306 citations), Surgery (637 citations) and Cancer Research (172 citations). Frédèric Selle has collaborated with scholars based in France, Italy and Spain. Frequent co-authors include Thierry André, Christophe Louvet, Roman Rouzier, Émile Daraï, E. Chéreau, Jean‐Pierre Lotz, Pascal Hammel, Philippe Ruszniewski, Aimery de Gramont and Jacques Balosso. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, International Journal of Gynecological Cancer, Gynecologic Oncology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.